{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:15Z","timestamp":1787008635282,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Dubai Harvard Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Observational studies have demonstrated the effectiveness of a fluoroquinolone-based regimen to treat individuals presumed to be infected with drug-resistant tuberculosis (DR-TB). We sought to assess the feasibility of this approach in an urban setting in South Asia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From February 2016 until March 2017, all household contacts of DR-TB patients enrolled at the Indus Hospital were screened for TB symptoms at home. Children aged 0\u201317 years, symptomatic adults, and those with an immunocompromising condition (human immunodeficiency virus, diabetes, or malnutrition) were evaluated for TB disease. Contacts diagnosed with TB disease were started on treatment. Contacts without TB disease aged &amp;lt;5 years, contacts aged between 5 and 17 years with either a positive tuberculin skin test or an immunocompromising condition, or contacts aged \u226518 years with an immunocompromising condition were offered 6 months of treatment with a fluoroquinolone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred households with 800 contacts were enrolled: 353 (44.1%) individuals aged \u226417 years with a median age of 19 years (interquartile range, 10\u201332); 423 (52.9%) were males. In total, 737 (92.1%) individuals were screened, of which 8 were already on treatment for TB (1.1%); another 3 (0.4%) contacts were diagnosed with TB disease and started on treatment. Of 215 eligible for infection treatment, 172 (80.0%) contacts initiated and 121 (70.3%) completed treatment. No TB disease or significant adverse events were observed during 12 months of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fluoroquinolone-based treatment for contacts with presumed DR-TB infection is feasible and well tolerated in a high TB burden setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciz502","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T15:11:20Z","timestamp":1560265880000},"page":"1958-1965","source":"Crossref","is-referenced-by-count":24,"title":["Tuberculosis Preventive Therapy for Individuals Exposed to Drug-resistant Tuberculosis: Feasibility and Safety of a Community-based Delivery of Fluoroquinolone-containing Preventive Regimen"],"prefix":"10.1093","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4875-9916","authenticated-orcid":false,"given":"Amyn A","family":"Malik","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"},{"name":"Interactive Research and Development Global, Singapore"},{"name":"Emory University Rollins School of Public Health, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junaid","family":"Fuad","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Siddiqui","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Amanullah","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"},{"name":"Interactive Research and Development Global, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jaswal","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Barry","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat","family":"Jabeen","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razia","family":"Fatima","sequence":"first","affiliation":[{"name":"National TB Control Program, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney M","family":"Yuen","sequence":"first","affiliation":[{"name":"Department of Global Health and Social Medicine, Harvard Medical School"},{"name":"Division of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Salahuddin","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"},{"name":"Indus Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir J","family":"Khan","sequence":"first","affiliation":[{"name":"Global Health Directorate, Indus Health Network, Karachi, Pakistan"},{"name":"Interactive Research and Development Global, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmaan","family":"Keshavjee","sequence":"first","affiliation":[{"name":"Department of Global Health and Social Medicine, Harvard Medical School"},{"name":"Division of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Partners In Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes C","family":"Becerra","sequence":"first","affiliation":[{"name":"Department of Global Health and Social Medicine, Harvard Medical School"},{"name":"Division of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Partners In Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidah","family":"Hussain","sequence":"first","affiliation":[{"name":"Interactive Research and Development Global, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"2020041501053535000_CIT0001","volume-title":"Global tuberculosis control report 2018","author":"World Health Organization","year":"2018"},{"key":"2020041501053535000_CIT0002","volume-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"Review on Antimicrobial Resistance","year":"2016"},{"key":"2020041501053535000_CIT0003","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/592991","article-title":"Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa","volume":"198","author":"Andrews","year":"2008","journal-title":"J Infect Dis"},{"key":"2020041501053535000_CIT0004","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3201\/eid2111.150813","article-title":"Epidemiology of primary multidrug-resistant tuberculosis, Vladimir Region, Russia","volume":"21","author":"Ershova","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2020041501053535000_CIT0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(16)30418-2","article-title":"Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation","volume":"17","author":"Yang","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020041501053535000_CIT0006","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/cit643","article-title":"Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis","volume":"58","author":"Shah","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020041501053535000_CIT0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/aje\/152.3.247","article-title":"Lifetime risks, incubation period, and serial interval of tuberculosis","volume":"152","author":"Vynnycky","year":"2000","journal-title":"Am J Epidemiol"},{"key":"2020041501053535000_CIT0008","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"2020041501053535000_CIT0009","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5588\/ijtld.13.0593","article-title":"High tuberculosis prevalence in children exposed at home to drug-resistant tuberculosis","volume":"18","author":"Amanullah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020041501053535000_CIT0010","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"2020041501053535000_CIT0011","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","article-title":"Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection","volume":"386","author":"Rangaka","year":"2015","journal-title":"Lancet"},{"key":"2020041501053535000_CIT0012","author":"Zero TB Initiative"},{"key":"2020041501053535000_CIT0013","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/S0140-6736(15)00401-8","article-title":"Tuberculosis\u2013getting to zero","volume":"386","author":"Das","year":"2015","journal-title":"Lancet"},{"key":"2020041501053535000_CIT0014","volume-title":"Post-exposure management of multidrug-resistant tuberculosis contacts: evidence-based recommendations","author":"Seddon","year":"2015"},{"key":"2020041501053535000_CIT0015","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018"},{"key":"2020041501053535000_CIT0016","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020041501053535000_CIT0017","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/INF.0b013e3181783aca","article-title":"Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003","volume":"27","author":"Feja","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"2020041501053535000_CIT0018","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study","volume":"57","author":"Seddon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020041501053535000_CIT0019","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3201\/eid2103.141313","article-title":"Moxifloxacin prophylaxis against MDR TB, New York, New York, USA","volume":"21","author":"Trieu","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2020041501053535000_CIT0020","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/cid\/cix208","article-title":"Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis","volume":"64","author":"Marks","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020041501053535000_CIT0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2016.11.006","article-title":"Preventive therapy for latent tuberculosis infection\u2014the promise and the challenges","volume":"56","author":"Fox","year":"2017","journal-title":"Int J Infect Dis"},{"key":"2020041501053535000_CIT0022","doi-asserted-by":"crossref","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"4","author":"Johnston","year":"2009","journal-title":"PLoS One"},{"key":"2020041501053535000_CIT0023","doi-asserted-by":"crossref","first-page":"e20162706","DOI":"10.1542\/peds.2016-2706","article-title":"The use of systemic and topical fluoroquinolones","volume":"138","author":"Jackson","year":"2016","journal-title":"Pediatrics"},{"key":"2020041501053535000_CIT0024","volume-title":"Fluoroquinolone use in paediatrics: focus on safety and place in therapy","author":"Goldman","year":"2011"},{"key":"2020041501053535000_CIT0025","doi-asserted-by":"crossref","first-page":"935","DOI":"10.5588\/ijtld.17.0061","article-title":"A systematic review of national policies for the management of persons exposed to tuberculosis","volume":"21","author":"Rodriguez","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020041501053535000_CIT0026","volume-title":"How to care for people exposed to drug-resistant tuberculosis: a practical guide","year":"2018","edition":"1st ed"},{"key":"2020041501053535000_CIT0027","volume-title":"A best-practice framework of program indicators for monitoring a comprehensive approach to the tuberculosis epidemic","author":"Zero TB Initiative","year":"2017"},{"key":"2020041501053535000_CIT0028","doi-asserted-by":"crossref","first-page":"e0182185","DOI":"10.1371\/journal.pone.0182185","article-title":"Child contact management in high tuberculosis burden countries: a mixed-methods systematic review","volume":"12","author":"Szkwarko","year":"2017","journal-title":"PLoS One"},{"key":"2020041501053535000_CIT0029","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis","volume":"41","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"key":"2020041501053535000_CIT0030","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2020041501053535000_CIT0031","doi-asserted-by":"crossref","first-page":"e0172881","DOI":"10.1371\/journal.pone.0172881","article-title":"Symptom screening rules to identify active pulmonary tuberculosis: findings from the Zambian South African Tuberculosis and HIV\/AIDS Reduction (ZAMSTAR) trial prevalence surveys","volume":"12","author":"Claassens","year":"2017","journal-title":"PLoS One"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz502\/29173800\/ciz502.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/9\/1958\/33045636\/ciz502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/9\/1958\/33045636\/ciz502.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T01:05:50Z","timestamp":1586912750000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/9\/1958\/5514486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,6,12]]},"published-print":{"date-parts":[[2020,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz502","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5,1]]},"published":{"date-parts":[[2019,6,12]]}}}